血清维生素B12可作为儿童甲基丙二酸血症诊断的辅助指标
该单中心研究纳入241例甲基丙二酸血症(MMA)患儿和241例健康匹配对照,用酶免疫法测血清维生素B12(VitB12)。结果显示MMA组血清VitB12高于对照组(p < 0.001),VitB12可区分MMA与健康儿童(p < 0.001),并与同型半胱氨酸、氨联合鉴别cblC型和mut型MMA(p < 0.001);升高的VitB12是MMA临床发作的独立预测因素(p < 0.001)。结论认为血清VitB12可作为儿童MMA早期诊断生物标志物。
要点
- MMA患儿血清VitB12水平较健康对照升高(p < 0.001)。
- 血清VitB12可区分MMA与健康儿童(p < 0.001)。
- VitB12联合同型半胱氨酸和氨可分别鉴别cblC与mut型MMA(p < 0.001)。
核心结论
- 血清VitB12可作为儿童MMA早期诊断的生物标志物。
研究设计与样本
- 单中心研究,纳入241例MMA患儿和241例健康匹配对照,用酶免疫法测血清VitB12。
主要发现
- MMA组血清VitB12水平高于对照组(p < 0.001)。
- 血清VitB12可区分MMA患儿与健康儿童(p < 0.001)。
- 血清VitB12联合同型半胱氨酸和氨分别鉴别cblC型和mut型MMA(p < 0.001)。
- 在cblC型MMA中,同型半胱氨酸、叶酸、氨、NLR和红细胞与血清VitB12相关(p < 0.001)。
- 在mut型MMA中,同型半胱氨酸、氨和红细胞与血清VitB12相关(p < 0.001);升高的VitB12是MMA临床发作的独立预测因素(p < 0.001)。
关键数值与推荐
- 血清VitB12区分MMA与健康儿童p < 0.001。
- VitB12联合同型半胱氨酸和氨鉴别cblC与mut型MMA的p < 0.001。
- cblC型中同型半胱氨酸、叶酸、氨、NLR、红细胞与VitB12相关p < 0.001。
- mut型中同型半胱氨酸、氨、红细胞与VitB12相关p < 0.001。
- 升高的VitB12为MMA临床发作独立预测因素p < 0.001。
临床怎么用
- 对疑似MMA的儿童可检测血清VitB12作为早期诊断辅助指标。
- 联合同型半胱氨酸和氨有助于鉴别cblC型与mut型MMA。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Vitamin B12 (cobalamin, VitB12) is an essential coenzyme of methylmalonyl-CoA mutase and methionine synthase. Variations in VitB12 metabolism, absorption, transport, or intake may cause changes in methylmalonic acidemia (MMA) biomarkers. We aimed to investigate whether serum Vitamin B12 levels could be used in the early detection of MMA. MATERIALS AND METHODS: We included 241 children with MMA and 241 healthy matched controls. We measured serum VitB12 levels by an enzyme immunoassay and investigated the relationship between abnormal VitB12 levels and hematologic parameters as potential risk factors for MMA symptoms. RESULTS: Compared with controls, the serum levels of VitB12 were increased in the MMA group (p < 0.001). Serum VitB12 distinguished patients with MMA from healthy children (p < 0.001). Serum VitB12 combined with homocysteine and ammonia identified cblC and mut type MMA, respectively (p < 0.001). Homocysteine, folate, ammonia, NLR, and red blood cells contributed to serum VitB12 in cblC type MMA (p < 0.001); homocysteine, ammonia, and red blood cells, contributed in mut type MMA (p < 0.001); and elevated VitB12 was an independent predictor of MMA clinical onset (p < 0.001). CONCLUSION: Serum VitB12 can be used as an early diagnostic biomarker for MMA in children.
引用
- Du M, Wu S, Su C, et al. Serum vitamin B12 is a promising auxiliary index for the diagnosis of methylmalonic acidemia in children: A single center study in China. Clin Chim Acta. 2023. PMID: 37217112. doi:10.1016/j.cca.2023.117409
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。